Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment.
We work with biopharmaceutical companies to offer services and solutions that improve your probability of success, connecting insights with superior delivery for better outcomes. Quintiles’ shares your goals and collaborates with you, bringing an industry recognised depth of expertise and breadth of perspective to shape better ideas.
Our award-winning processes, people and technology drive predictable and efficient delivery globally. With more than 33,000 employees working in more than 100 countries, we have helped develop or commercialise all of the top 75 best-selling products on the market in 2014. It is all done with an unwavering dedication to ethics and high quality, in the pursuit of success in human measures.
Shifts in healthcare are driving transformation. Advances in science, analytics and therapeutic knowledge offer the promise of better treatments. The healthcare industry has great opportunity to conquer disease, working together differently across the healthcare system with attention on integration, evidence and value. Quintiles has a unique vantage point on this transformation and brings a fully integrated approach to build biopharma and life sciences solutions.
Our Product Development group enables biopharmaceutical R&D and medical device companies, government and non-government organisations, and generic and biosimilar customers outsource clinical development, from first-in-human studies to post-launch monitoring. Our services provide the expertise and capabilities as well as the systems and analytical expertise necessary at each stage of development. Clinical solutions and services include project management and clinical monitoring functions for conducting multi-site trials (generally Phase II-IV), collectively known as ‘core clinical.’
Our global laboratories, data management, biostatistics, safety and pharmacovigilance, early clinical development (generally Phase I), and strategic planning and design services enable us to provide end-to-end solutions to our customers. Consulting provides strategy and management consulting services based on life science expertise and advanced analytics, as well as regulatory and compliance consulting services.
Our Integrated Healthcare Services (IHS) address the outsourced commercial needs of biopharmaceutical customers as well as the needs of the broader healthcare sector for value-based analyses, research studies and evidence-based medicine. Services include commercial services such as sales representatives, strategy, market access, marketing communications and other areas related to commercialisation.
Outcomes research, including drug therapy analysis, real-world research and evidence-based medicine (with research studies to prove a drug’s value) are also part of our IHS offering along with comparative and cost-effectiveness research, clinical management analytics, decision support services, medication adherence and health outcome optimisation services. We also offer web-based systems for measuring quality improvement.